OCULAR THERAPEUTIX INC

Ocular Therapeutix (OCUL) dips 2.56% as price falls below its 200‑day SMA; explore hydrogel innovation, market trends, and growth prospects.

OCUL’s price lift to $6.51 highlights a 2.1x valuation vs peers, positioning Ocular Therapeutix’s hydrogel tech as a buying window amid sector gains.